Skip to main content

Table 1 Categorical arrangements for the different cell types in 160 rectal cancer patients.

From: Local and distant recurrences in rectal cancer patients are predicted by the nonspecific immune response; specific immune response has only a systemic effect - a histopathological and immunohistochemical study

cell type (antibody) intratumoral peritumoral
   cells / mm2   % of patients cells / mm2   % of patients
eosinophils (EG-2)   n = 159    n = 140  
  none/few 0-10   29 0-50   31
  moderate 11-50   50 51 - 200   43
  many > 50   21 > 200   26
neutrophils (elastase)   n = 160    n = 152  
  none/few 0-5   21 0 - 75   24
  moderate 6 - 50   54    
  many > 50   25 > 75   76
mast cells (tryptase)   n= 160    n = 151  
  none/few 0 -5   19 0-30   25
  moderate 6 -50   52 31 -100   59
  many > 50   29 > 100   16
macrophages (CD68)   n = 159     
  none/few 0-50   28    
  moderate 51 -150   50    
  many > 150   22    
NK cells (CD56)   n = 159    n = 136  
  none 0   33 0   43
  moderate/many > 0   67 > 0   57
T cells (CD3)   n = 158    n = 157  
  none/few 0-55   27 0-300   20
  moderate 56-105   36 301 - 500   51
  many >105   37 > 500   29
CD4+ cells    n = 156    n = 130  
  none/few 0-30   43 0-20   24
  moderate 31 -65   26 21 -110   50
  many >65   31 > 110   26
CD8+ cells    n = 159    n = 122  
  none/few 0-15   26 0-135   77
  moderate 16-75   47    
  many >75   27 > 135   23
  1. Peritumoral infiltrate could not be reliably determined in all patients, because of the absence of invasive front in several tumor samples.